Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DGKα-IN-4 (example 432), an inhibitor of DGKα with an IC50 value of 0.1 nM. This compound notably potentiates the anti-tumor efficacy of anti-PD-1 therapy through augmentation of T cell proliferation and function. Additionally, DGKα-IN-3 shows promise for research in cancer and immunology.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | DGKα-IN-4 (example 432), an inhibitor of DGKα with an IC50 value of 0.1 nM. This compound notably potentiates the anti-tumor efficacy of anti-PD-1 therapy through augmentation of T cell proliferation and function. Additionally, DGKα-IN-3 shows promise for research in cancer and immunology. |
Molecular Weight | 523.58 |
Formula | C30H29N5O4 |
CAS No. | 2648723-43-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DGKα-IN-4 2648723-43-5 inhibitor inhibit